Phaeohyphomycosis Due to Exophiala oligosperma in an Immunocompromised Host

J Rheumatol. 2019 Jun;46(6):652. doi: 10.3899/jrheum.180774.

Authors

Hirofumi Nishikawa¹, Yoshinori Taniguchi²

Affiliations

¹ Department of Endocrinology, Metabolism, Nephrology and Rheumatology, Kochi Medical School Hospital, Nankoku, Kochi, Japan.
² Department of Endocrinology, Metabolism, Nephrology and Rheumatology, Kochi Medical School Hospital, Nankoku, Kochi, Japan. yoshii.tan@gmail.com.

PMID: 31154445
DOI: 10.3899/jrheum.180774

No abstract available

Publication types

Case Reports

MeSH terms

Aged, 80 and over
Antifungal Agents / therapeutic use
Drug Therapy, Combination
Exophiala / isolation & purification*
Female
Flucytosine / therapeutic use
Humans
Immunocompromised Host*
Itraconazole / therapeutic use
Phaeohyphomycosis / complications
Phaeohyphomycosis / diagnosis*
Phaeohyphomycosis / drug therapy
Still's Disease, Adult-Onset / complications*
Treatment Outcome

Substances

Antifungal Agents
Itraconazole
Flucytosine